HEADER TRANSFERASE 31-MAR-17 5NK7 TITLE CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH TITLE 2 COMPOUND 2A COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPHRIN TYPE-A RECEPTOR 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EPITHELIAL CELL KINASE,TYROSINE-PROTEIN KINASE RECEPTOR ECK; COMPND 5 EC: 2.7.10.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EPHA2, ECK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS INHIBITOR, COMPLEX, PROTEIN TYROSINE KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.KUDLINZKI,V.L.LINHARD,K.WITT,S.L.GANDE,K.SAXENA,S.HEINZLMEIR, AUTHOR 2 G.MEDARD,B.KUESTER,H.SCHWALBE REVDAT 5 17-JAN-24 5NK7 1 REMARK REVDAT 4 14-AUG-19 5NK7 1 REMARK REVDAT 3 12-JUN-19 5NK7 1 AUTHOR REVDAT 2 28-JUN-17 5NK7 1 JRNL REVDAT 1 07-JUN-17 5NK7 0 JRNL AUTH S.HEINZLMEIR,J.LOHSE,T.TREIBER,D.KUDLINZKI,V.LINHARD, JRNL AUTH 2 S.L.GANDE,S.SREERAMULU,K.SAXENA,X.LIU,M.WILHELM,H.SCHWALBE, JRNL AUTH 3 B.KUSTER,G.MEDARD JRNL TITL CHEMOPROTEOMICS-AIDED MEDICINAL CHEMISTRY FOR THE DISCOVERY JRNL TITL 2 OF EPHA2 INHIBITORS. JRNL REF CHEMMEDCHEM V. 12 999 2017 JRNL REFN ESSN 1860-7187 JRNL PMID 28544567 JRNL DOI 10.1002/CMDC.201700217 REMARK 2 REMARK 2 RESOLUTION. 1.89 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.89 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.36 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 21341 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.171 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.200 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1068 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.3643 - 3.7766 1.00 2571 136 0.1449 0.1548 REMARK 3 2 3.7766 - 2.9979 1.00 2535 133 0.1440 0.1777 REMARK 3 3 2.9979 - 2.6191 1.00 2533 134 0.1673 0.2134 REMARK 3 4 2.6191 - 2.3797 1.00 2525 133 0.1694 0.1989 REMARK 3 5 2.3797 - 2.2091 1.00 2524 132 0.1796 0.2064 REMARK 3 6 2.2091 - 2.0789 1.00 2537 134 0.1871 0.2217 REMARK 3 7 2.0789 - 1.9748 1.00 2518 132 0.2176 0.2723 REMARK 3 8 1.9748 - 1.8888 1.00 2530 134 0.2397 0.2791 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.300 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.41 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2433 REMARK 3 ANGLE : 0.949 3290 REMARK 3 CHIRALITY : 0.048 349 REMARK 3 PLANARITY : 0.004 420 REMARK 3 DIHEDRAL : 16.826 1499 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5NK7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-MAR-17. REMARK 100 THE DEPOSITION ID IS D_1200004082. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JUL-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918409 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS XDSAPP 2.0 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21343 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.889 REMARK 200 RESOLUTION RANGE LOW (A) : 38.356 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 3.830 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.3200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.89 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.780 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5I9U REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 37.5% MPD/PEG1000/PEG3350 (MD), 0.25 M REMARK 280 AMINO ACIDS MIX (MD), 0.1 M BUFFER SYSTEM 3 (MD) PH8.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 53.78300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 595 REMARK 465 ASP A 596 REMARK 465 PRO A 597 REMARK 465 ASN A 598 REMARK 465 GLN A 599 REMARK 465 ALA A 600 REMARK 465 VAL A 601 REMARK 465 LEU A 602 REMARK 465 LYS A 603 REMARK 465 THR A 634 REMARK 465 SER A 635 REMARK 465 SER A 636 REMARK 465 GLY A 637 REMARK 465 LYS A 638 REMARK 465 THR A 773 REMARK 465 THR A 774 REMARK 465 SER A 775 REMARK 465 GLY A 776 REMARK 465 SER A 897 REMARK 465 THR A 898 REMARK 465 SER A 899 REMARK 465 GLY A 900 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASN A 732 O HOH A 1101 2.08 REMARK 500 O HOH A 1101 O HOH A 1292 2.11 REMARK 500 O LEU A 760 N ARG A 762 2.17 REMARK 500 O HOH A 1262 O HOH A 1320 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 640 -62.09 -126.14 REMARK 500 ARG A 738 -20.08 77.31 REMARK 500 ARG A 738 -20.49 78.22 REMARK 500 ASP A 757 67.66 72.17 REMARK 500 LEU A 760 -146.41 -113.67 REMARK 500 SER A 761 -32.93 -30.06 REMARK 500 TYR A 791 27.83 -140.47 REMARK 500 TRP A 819 -120.20 52.19 REMARK 500 ALA A 877 71.90 -117.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8ZZ A 1001 DBREF 5NK7 A 596 900 UNP P29317 EPHA2_HUMAN 596 900 SEQADV 5NK7 GLY A 595 UNP P29317 EXPRESSION TAG SEQRES 1 A 306 GLY ASP PRO ASN GLN ALA VAL LEU LYS PHE THR THR GLU SEQRES 2 A 306 ILE HIS PRO SER CYS VAL THR ARG GLN LYS VAL ILE GLY SEQRES 3 A 306 ALA GLY GLU PHE GLY GLU VAL TYR LYS GLY MET LEU LYS SEQRES 4 A 306 THR SER SER GLY LYS LYS GLU VAL PRO VAL ALA ILE LYS SEQRES 5 A 306 THR LEU LYS ALA GLY TYR THR GLU LYS GLN ARG VAL ASP SEQRES 6 A 306 PHE LEU GLY GLU ALA GLY ILE MET GLY GLN PHE SER HIS SEQRES 7 A 306 HIS ASN ILE ILE ARG LEU GLU GLY VAL ILE SER LYS TYR SEQRES 8 A 306 LYS PRO MET MET ILE ILE THR GLU TYR MET GLU ASN GLY SEQRES 9 A 306 ALA LEU ASP LYS PHE LEU ARG GLU LYS ASP GLY GLU PHE SEQRES 10 A 306 SER VAL LEU GLN LEU VAL GLY MET LEU ARG GLY ILE ALA SEQRES 11 A 306 ALA GLY MET LYS TYR LEU ALA ASN MET ASN TYR VAL HIS SEQRES 12 A 306 ARG ASP LEU ALA ALA ARG ASN ILE LEU VAL ASN SER ASN SEQRES 13 A 306 LEU VAL CYS LYS VAL SER ASP PHE GLY LEU SER ARG VAL SEQRES 14 A 306 LEU GLU ASP ASP PRO GLU ALA THR TYR THR THR SER GLY SEQRES 15 A 306 GLY LYS ILE PRO ILE ARG TRP THR ALA PRO GLU ALA ILE SEQRES 16 A 306 SER TYR ARG LYS PHE THR SER ALA SER ASP VAL TRP SER SEQRES 17 A 306 PHE GLY ILE VAL MET TRP GLU VAL MET THR TYR GLY GLU SEQRES 18 A 306 ARG PRO TYR TRP GLU LEU SER ASN HIS GLU VAL MET LYS SEQRES 19 A 306 ALA ILE ASN ASP GLY PHE ARG LEU PRO THR PRO MET ASP SEQRES 20 A 306 CYS PRO SER ALA ILE TYR GLN LEU MET MET GLN CYS TRP SEQRES 21 A 306 GLN GLN GLU ARG ALA ARG ARG PRO LYS PHE ALA ASP ILE SEQRES 22 A 306 VAL SER ILE LEU ASP LYS LEU ILE ARG ALA PRO ASP SER SEQRES 23 A 306 LEU LYS THR LEU ALA ASP PHE ASP PRO ARG VAL SER ILE SEQRES 24 A 306 ARG LEU PRO SER THR SER GLY HET 8ZZ A1001 66 HETNAM 8ZZ ~{N}-(2-CHLORANYL-6-METHYL-PHENYL)-2-[[3-[[(3~{R}, HETNAM 2 8ZZ 4~{R})-3-FLUORANYLPIPERIDIN-4- HETNAM 3 8ZZ YL]CARBAMOYL]PHENYL]AMINO]-1,3-THIAZOLE-5-CARBOXAMIDE FORMUL 2 8ZZ C23 H23 CL F N5 O2 S FORMUL 3 HOH *227(H2 O) HELIX 1 AA1 HIS A 609 SER A 611 5 3 HELIX 2 AA2 THR A 653 GLN A 669 1 17 HELIX 3 AA3 ALA A 699 LYS A 707 1 9 HELIX 4 AA4 SER A 712 MET A 733 1 22 HELIX 5 AA5 ALA A 741 ARG A 743 5 3 HELIX 6 AA6 SER A 761 ASP A 767 1 7 HELIX 7 AA7 PRO A 780 THR A 784 5 5 HELIX 8 AA8 ALA A 785 ARG A 792 1 8 HELIX 9 AA9 THR A 795 THR A 812 1 18 HELIX 10 AB1 SER A 822 ASP A 832 1 11 HELIX 11 AB2 PRO A 843 TRP A 854 1 12 HELIX 12 AB3 GLU A 857 ARG A 861 5 5 HELIX 13 AB4 LYS A 863 ALA A 877 1 15 HELIX 14 AB5 PRO A 878 THR A 883 5 6 SHEET 1 AA1 5 VAL A 613 ALA A 621 0 SHEET 2 AA1 5 GLU A 626 LEU A 632 -1 O VAL A 627 N GLY A 620 SHEET 3 AA1 5 VAL A 641 LEU A 648 -1 O ILE A 645 N TYR A 628 SHEET 4 AA1 5 MET A 688 GLU A 693 -1 O ILE A 690 N LYS A 646 SHEET 5 AA1 5 LEU A 678 ILE A 682 -1 N GLY A 680 O ILE A 691 SHEET 1 AA2 2 ILE A 745 VAL A 747 0 SHEET 2 AA2 2 CYS A 753 VAL A 755 -1 O LYS A 754 N LEU A 746 CISPEP 1 LYS A 686 PRO A 687 0 0.60 SITE 1 AC1 20 VAL A 627 ALA A 644 ILE A 645 LYS A 646 SITE 2 AC1 20 GLU A 663 ILE A 690 THR A 692 GLU A 693 SITE 3 AC1 20 TYR A 694 MET A 695 GLU A 696 GLY A 698 SITE 4 AC1 20 LEU A 746 SER A 756 ARG A 792 HOH A1110 SITE 5 AC1 20 HOH A1131 HOH A1143 HOH A1239 HOH A1262 CRYST1 32.873 107.566 40.508 90.00 108.76 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.030420 0.000000 0.010331 0.00000 SCALE2 0.000000 0.009297 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026071 0.00000